HHS released a proposed rule on October 27 regarding the federal independent dispute resolution (IDR) process for the No Surprises Act. The rule focuses on early communication between payers and providers, the open negotiation period, batching, eligibility, administrative fee structure, and...Read More »
Pharmacy revenue generally is a top revenue driver at most organizations, but too often it’s treated similarly to other service lines within the organization that don’t have nearly the same charging complexities and nuances nor the impact to the bottom line...Read More »
The American Medical Association (AMA) recently approved the consolidation of more than 50 codes used to report COVID-19 vaccines, as well as the addition of several new codes.Read More »
